Employer Fertility Benefits and the New Federal Rule

If you're funding fertility care through a workplace benefit, you already know how fragile that arrangement can feel. The coverage exists because someone in HR, somewhere, decided it should. It can also disappear the same way.

That's the quiet anxiety underneath a policy story unfolding right now in Washington. A proposed federal rule from the Trump administration would change how employers structure their health offerings, and the country's largest infertility advocacy group has already pushed back, saying too many people still face barriers to fertility care and that the rule could make those barriers worse.¹

The details are technical. The stakes, if you're three rounds into IVF or pricing a surrogacy journey, are not.

What's actually being proposed

The specifics of the rule are still being analyzed, and the full impact on fertility benefits isn't yet settled. What's clear is that it touches employer-sponsored health plans — the same plans that, for a growing number of workers, now include some form of fertility coverage. RESOLVE, the national infertility association, has formally responded with concern, framing the rule as a potential setback at a moment when access is already uneven.¹

What the rule does not do: it doesn't automatically cancel anyone's current fertility benefit. Employer fertility coverage has expanded largely on a voluntary basis over the last several years, driven by competition for talent and by employees asking for it. A federal rule can shape the environment those decisions get made in, but most companies will still be choosing what to offer.

That's the part worth holding onto. The decision-makers are often closer to you than Washington is.

The gap between "best-in-class" and "bare minimum"

Here's something the policy conversation tends to obscure: there is an enormous range in what counts as a "fertility benefit."

On one end, you have employers working with specialized fertility benefit vendors who cover multiple IVF cycles, genetic testing, donor services, surrogacy support, and mental health care alongside it. On the other end, you have plans that technically include a diagnostic workup and nothing else — coverage that gets you a diagnosis and then a bill.

Industry guidance for HR teams reviewing their fertility vendors now includes questions about inclusivity (does the benefit work for single parents and LGBTQ+ families?), clinical quality, member experience, and whether the vendor is actually accountable for outcomes.² Those are the right questions. They're also questions most employees never get to see asked.

If the federal rule narrows what employers feel comfortable offering, the risk isn't that the best plans disappear overnight. The risk is that the floor drops — that smaller employers, or ones that were on the fence, decide it's safer to offer less.

What this means for you, specifically

A few honest scenarios:

If your benefit is already in place for this plan year: It's almost certainly safe for now. Mid-year changes to health benefits are rare and procedurally difficult. Use the time.

If you're planning treatment in the next 6–18 months: This is the window to confirm what's covered, get pre-authorizations in writing, and understand your plan's lifetime maximums. Don't assume next year's benefit will mirror this year's.

If you're job-hunting or weighing an offer: Fertility benefits vary wildly between employers in the same industry, sometimes the same building. Ask specifically. "Do you offer fertility benefits?" is not enough. Ask how many IVF cycles, whether medications are included, whether the benefit extends to surrogacy or donor gametes, and whether you need a medical diagnosis of infertility to qualify — that last one matters enormously for LGBTQ+ couples and single parents by choice.

If you work somewhere without coverage: You are not powerless. Employee resource groups, anonymous benefits surveys, and direct conversations with HR have driven much of the voluntary expansion of fertility coverage. Your ask is data.

The advocacy piece

RESOLVE recently launched its first Month of Action, a coordinated push to get more people involved in infertility advocacy at the state and federal level.³ The timing — running alongside the response to the proposed rule — isn't coincidence. Policy windows open and close fast, and the people most affected are often the ones least visible in the conversation, because they're tired, because they're grieving, because telling your fertility story to a stranger in a congressional office is a lot to ask of someone mid-cycle.

It's still worth knowing the door is open. Public comment periods on federal rules are real. So are state legislators who have never heard from a constituent about infertility coverage and have no reason to prioritize it until they do.

You don't have to become an activist. You can write one email.

What to actually ask, and of whom

If this story has you worried, the most useful next move isn't reading more headlines. It's getting clarity on what you have.

Ask your HR or benefits team:

What is the current lifetime maximum for fertility services on our plan?
Are medications covered, and through which pharmacy benefit?
Does the plan require a medical diagnosis of infertility, or is family-building coverage available without one?
Is surrogacy, egg/sperm donation, or adoption assistance included?
When is open enrollment, and is the benefit expected to change?

Ask your clinic's financial counselor:

What does my specific plan actually pay for, based on cases they've billed?
What gets denied most often, and how do appeals usually go?

Write these answers down. Keep them somewhere you can find at 11pm when the worry hits.

The rule may change. Your employer's offering may change. The thing you can control today is knowing exactly where you stand — so that if something does shift, you're not finding out from a benefits summary in November.

You've already done the hardest part, which is deciding this matters enough to fight for. The paperwork is just paperwork.